TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

SP Hussain, J Schwank, F Staib, XW Wang, CC Harris - Oncogene, 2007 - nature.com
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and
the major risk factors include chronic infections with the hepatitis B (HBV) or C (HCV) virus …

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer

AJ Dannenberg, NK Altorki, JO Boyle, C Dang… - The lancet …, 2001 - thelancet.com
Understanding the mechanisms underlying carcinogenesis provides insights that are
necessary for the development of therapeutic strategies to prevent cancer …

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

AJ Dannenberg, SM Lippman, JR Mann… - Journal of clinical …, 2005 - ascopubs.org
Understanding the mechanisms underlying carcinogenesis provides insights that are
necessary for the development of therapeutic strategies to prevent cancer …

[HTML][HTML] The prognostic molecular markers in hepatocellular carcinoma

LX Qin, ZY Tang - World journal of gastroenterology, 2002 - ncbi.nlm.nih.gov
The prognosis of hepatocellular carcinoma (HCC) still remains dismal, although many
advances in its clinical study have been made. It is important for tumor control to identify the …

Cyclooxygenase–2 Promotes Hepatocellular Carcinoma Cell Growth Through Akt Activation: Evidence for Akt Inhibition in Celecoxib–Induced Apoptosis

J Leng, C Han, JA Demetris, GK Michalopoulos… - Hepatology, 2003 - journals.lww.com
Abstract Cyclooxygenase–2 (COX–2)–controlled prostaglandin (PG) metabolism recently
has been implicated in the pathogenesis of hepatocellular carcinoma (HCC). However, the …

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations

T Shono, PJ Tofilon, JM Bruner, O Owolabi, FF Lang - Cancer research, 2001 - AACR
Abstract Cyclooxygenase (COX)-2, the inducible isoform of prostaglandin H synthase, has
been implicated in the growth and progression of a variety of human cancers. Although COX …

Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of …

MA Rahman, DK Dhar, E Yamaguchi, S Maruyama… - Clinical Cancer …, 2001 - AACR
Expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) has
been reported to be responsible for enhanced tumor growth and angiogenesis in various …

Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2

K Lim, C Han, Y Dai, M Shen, T Wu - Molecular cancer therapeutics, 2009 - AACR
Hepatocellular carcinoma (HCC) is a common human cancer with high mortality, and
currently, there is no effective chemoprevention or systematic treatment. Recent evidence …

[HTML][HTML] Omega-3 fatty acids to augment cancer therapy

WE Hardman - The Journal of nutrition, 2002 - Elsevier
The results of animal studies have demonstrated that the consumption of omega-3 fatty
acids can slow the growth of cancer xenografts, increase the efficacy of chemotherapy and …

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398

SH Bae, ES Jung, YM Park, BS Kim, BK Kim… - Clinical Cancer …, 2001 - AACR
Abstract Cyclooxygenase-2 (COX-2) has been suggested to be associated with
carcinogenesis. In hepatocellular carcinoma (HCC), the expression pattern of COX-2 protein …